| ZDV(= AZT) | Zidovudine |
|---|---|
| AZT | Aschheim-Zondek test; azidothymidine; 3'-azido-3'-deoxythymidine; zidovudine (azidothymidine) |
| ZDV | zidovudine |
| ZDV | Zidovudine |
|---|---|
| AZT | and Zidovudine |
| zidovudine | <drug> A nucleoside analogue used to slow replication of HIV AZT is approved for the initial treatment of HIV infection. AZT is increasingly administered in combination with other antiviral drugs, especially 3TC (a combination that is under consideration by the FDA as another initial treatment regimen for HIV) as well as ddC (an FDA-approved combination for persons with progressive disease and CD4 cell counts below 300). Possible side effects include bone marrow suppression leading to anaemia, leukopenia or neutropenia nausea, muscle weakness and headaches. (09 Oct 1997) |
|---|---|
| lamivudine | <chemical> A reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease. Pharmacological action: anti-HIV agents, reverse transcriptase inhibitors. Chemical name: 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)- (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|